Fortress Biotech, Inc. (FBIO)
Nasdaq: FBIO · Pharmaceutical Preparations · Bay Harbor Islands, FL · filing with the SEC since 2008
Filings
377 filings since 2017 beside 162 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026Due nextNon-accelerated filer and smaller reporting company
10-Q
Quarterly report for the quarter ending Sep 30, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end.
by Nov 14, 2026
10-K
Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends.
by Mar 31, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 44 days after the quarter ended. The proxy statement was last filed Apr 28, 2026.
Filings a yearinsider forms included
4359603979876131
2026 counts to Nov 13, 2026.
Officer or director change (8-K item 5.02): 3 times in the last 36 months, the newest Apr 16, 2025.SEC letters: 8 in the last 36 months, the newest Dec 16, 2025.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Feb 23, 2026
8-K items 1.01, 2.03, 8.01, 9.01
Major agreement signed; New debt or obligation taken on; Other event · Current report
Feb 22, 2026
Dec 15, 2025
8-K items 1.01, 2.03, 3.02
Major agreement signed; New debt or obligation taken on; Shares sold without registration · Current report
Dec 12, 2025
Jun 5, 2025
8-K items 2.01, 9.01
Purchase or sale of a business completed · Current report
May 30, 2025
40 of 377 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.